Diabetes, Vol 48, Issue 10 2022-2027, Copyright © 1999 by American Diabetes Association

ARTICLES

Metabolic impact of glucokinase overexpression in liver: lowering of blood glucose in fed rats is accompanied by hyperlipidemia

RM O'Doherty, DL Lehman, S Telemaque-Potts and CB Newgard
Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas 75235-9040, USA.

The balance between hepatic glucose uptake and production is perturbed in both major forms of diabetes. It has been suggested that pharmacologic or genetic methods for enhancing glucokinase (GK) enzymatic activity in liver might be a means of increasing glucose disposal and lowering blood glucose in diabetic patients. To better evaluate this possibility, we used a recombinant adenovirus containing the cDNA encoding GK (AdCMV-GKL) to achieve overexpression of the enzyme at different levels in liver of normal rats. In a first set of experiments, in rats fasted for 18 h, AdCMV-GKL infusion caused a 211% increase in hepatic GK activity relative to animals infused with a control virus (AdCMV-betaGAL). AdCMV-GKL-treated fasted rats exhibited no significant changes in circulating glucose, free fatty acids (FFAs), lactate, beta-hydroxybutyrate, or insulin levels relative to controls, whereas triglyceride (TG) levels were slightly increased (53%). In a second set of studies, in rats fed ad libitum, GK was overexpressed in liver by 3- and 6.4-fold. Animals with the lower degree of GK overexpression exhibited no significant changes in circulating glucose, FFAs, insulin, TG, or lactate levels relative to controls that received a virus encoding a catalytically inactive mutant GK (AdCMV-GK203), but did show a modest increase in lactate (58%) relative to AdCMV-betaGAL-infused controls. In contrast, the higher level of GK overexpression caused a 38% decrease in blood glucose levels and a 67% decrease in circulating insulin levels relative to AdCMV-GK203-infused animals. The decline in glucose levels was accompanied by a 190% increase in circulating TG and a 310% increase in circulating FFAs; total plasma cholesterol was unaffected. Finally, fasted animals treated with AdCMV-GKL had 5.4 times as much liver glycogen as AdCMV-betaGAL-treated controls; no significant increases in liver glycogen were observed at either level of GK overexpression in ad libitum-fed rats relative to fed controls. In sum, levels of hepatic GK overexpression associated with a decline in blood glucose are accompanied by equally dramatic increases in FFAs and TG, raising concerns about manipulation of liver GK activity as a viable strategy for treatment of diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. Orho-Melander, O. Melander, C. Guiducci, P. Perez-Martinez, D. Corella, C. Roos, R. Tewhey, M. J. Rieder, J. Hall, G. Abecasis, et al. Common Missense Variant in the Glucokinase Regulatory Protein Gene Is Associated With Increased Plasma Triglyceride and C-Reactive Protein but Lower Fasting Glucose Concentrations Diabetes, November 1, 2008; 57(11): 3112 - 3121. [Abstract] [Full Text] [PDF]

				V. Koya, S. Lu, Y.-P. Sun, D. L. Purich, M. A. Atkinson, S.-W. Li, and L.-J. Yang Reversal of Streptozotocin-Induced Diabetes in Mice by Cellular Transduction With Recombinant Pancreatic Transcription Factor Pancreatic Duodenal Homeobox-1: A Novel Protein Transduction Domain-Based Therapy Diabetes, March 1, 2008; 57(3): 757 - 769. [Abstract] [Full Text] [PDF]

				R. Yang, D. M. Wilcox, D. L. Haasch, P. M. Jung, P. T. Nguyen, M. J. Voorbach, S. Doktor, S. Brodjian, E. N. Bush, E. Lin, et al. Liver-specific Knockdown of JNK1 Up-regulates Proliferator-activated Receptor {gamma} Coactivator 1beta and Increases Plasma Triglyceride despite Reduced Glucose and Insulin Levels in Diet-induced Obese Mice J. Biol. Chem., August 3, 2007; 282(31): 22765 - 22774. [Abstract] [Full Text] [PDF]

				N. Morral, H. J. Edenberg, S. R. Witting, J. Altomonte, T. Chu, and M. Brown Effects of glucose metabolism on the regulation of genes of fatty acid synthesis and triglyceride secretion in the liver J. Lipid Res., July 1, 2007; 48(7): 1499 - 1510. [Abstract] [Full Text] [PDF]

				Diabetes Genetics Initiative of Broad Institute of, R. Saxena, B. F. Voight, V. Lyssenko, N. P. Burtt, P. I. W. de Bakker, H. Chen, J. J. Roix, S. Kathiresan, J. N. Hirschhorn, et al. Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels Science, June 1, 2007; 316(5829): 1331 - 1336. [Abstract] [Full Text] [PDF]

				R. Basu, A. Basu, C. M. Johnson, W. F. Schwenk, and R. A. Rizza Insulin Dose-Response Curves for Stimulation of Splanchnic Glucose Uptake and Suppression of Endogenous Glucose Production Differ in Nondiabetic Humans and Are Abnormal in People With Type 2 Diabetes Diabetes, August 1, 2004; 53(8): 2042 - 2050. [Abstract] [Full Text] [PDF]

				J. J. Collier and D. K. Scott Sweet Changes: Glucose Homeostasis Can Be Altered by Manipulating Genes Controlling Hepatic Glucose Metabolism Mol. Endocrinol., May 1, 2004; 18(5): 1051 - 1063. [Abstract] [Full Text] [PDF]

				A. L. Gloyn, K. Noordam, M. A.A.P. Willemsen, S. Ellard, W. W.K. Lam, I. W. Campbell, P. Midgley, C. Shiota, C. Buettger, M. A. Magnuson, et al. Insights Into the Biochemical and Genetic Basis of Glucokinase Activation From Naturally Occurring Hypoglycemia Mutations Diabetes, September 1, 2003; 52(9): 2433 - 2440. [Abstract] [Full Text] [PDF]

				C. C. Greenberg, K. N. Meredith, L. Yan, and M. J. Brady Protein Targeting to Glycogen Overexpression Results in the Specific Enhancement of Glycogen Storage in 3T3-L1 Adipocytes J. Biol. Chem., August 15, 2003; 278(33): 30835 - 30842. [Abstract] [Full Text] [PDF]

				A. Vella, A. S. Reed, N. Charkoudian, P. Shah, R. Basu, A. Basu, M. J. Joyner, and R. A. Rizza Glucose-induced suppression of endogenous glucose production: dynamic response to differing glucose profiles Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E25 - E30. [Abstract] [Full Text] [PDF]

				R. Yang and C. B. Newgard Hepatic Expression of a Targeting Subunit of Protein Phosphatase-1 in Streptozotocin-diabetic Rats Reverses Hyperglycemia and Hyperphagia Despite Depressed Glucokinase Expression J. Biol. Chem., June 20, 2003; 278(26): 23418 - 23425. [Abstract] [Full Text] [PDF]

				Y. Gao, K. Walder, T. Sunderland, L. Kantham, H. C. Feng, M. Quick, N. Bishara, A. de Silva, G. Augert, J. Tenne-Brown, et al. Elevation in Tanis Expression Alters Glucose Metabolism and Insulin Sensitivity in H4IIE Cells Diabetes, April 1, 2003; 52(4): 929 - 934. [Abstract] [Full Text] [PDF]

				H. B.T. Christesen, B. B. Jacobsen, S. Odili, C. Buettger, A. Cuesta-Munoz, T. Hansen, K. Brusgaard, O. Massa, M. A. Magnuson, C. Shiota, et al. The Second Activating Glucokinase Mutation (A456V): Implications for Glucose Homeostasis and Diabetes Therapy Diabetes, April 1, 2002; 51(4): 1240 - 1246. [Abstract] [Full Text] [PDF]

				M. Hawkins, I. Gabriely, R. Wozniak, C. Vilcu, H. Shamoon, and L. Rossetti Fructose Improves the Ability of Hyperglycemia Per Se to Regulate Glucose Production in Type 2 Diabetes Diabetes, March 1, 2002; 51(3): 606 - 614. [Abstract] [Full Text] [PDF]

				M. Veiga-da-Cunha and E. Van Schaftingen Identification of Fructose 6-Phosphate- and Fructose 1-Phosphate-binding Residues in the Regulatory Protein of Glucokinase J. Biol. Chem., March 1, 2002; 277(10): 8466 - 8473. [Abstract] [Full Text] [PDF]

				C. Wu, D. A. Okar, C. B. Newgard, and A. J. Lange Increasing fructose 2,6-bisphosphate overcomes hepatic insulin resistance of type 2 diabetes Am J Physiol Endocrinol Metab, January 1, 2002; 282(1): E38 - E45. [Abstract] [Full Text] [PDF]

				D. Becard, I. Hainault, D. Azzout-Marniche, L. Bertry-Coussot, P. Ferre, and F. Foufelle Adenovirus-Mediated Overexpression of Sterol Regulatory Element Binding Protein-1c Mimics Insulin Effects on Hepatic Gene Expression and Glucose Homeostasis in Diabetic Mice Diabetes, November 1, 2001; 50(11): 2425 - 2430. [Abstract] [Full Text] [PDF]

				R. H.J. Bandsma, C. H. Wiegman, A. W. Herling, H.-J. Burger, A. ter Harmsel, A. J. Meijer, J. A. Romijn, D.-J. Reijngoud, and F. Kuipers Acute Inhibition of Glucose-6-Phosphate Translocator Activity Leads to Increased De Novo Lipogenesis and Development of Hepatic Steatosis Without Affecting VLDL Production in Rats Diabetes, November 1, 2001; 50(11): 2591 - 2597. [Abstract] [Full Text] [PDF]

				U. J. Desai, E. D. Slosberg, B. R. Boettcher, S. L. Caplan, B. Fanelli, Z. Stephan, V. J. Gunther, M. Kaleko, and S. Connelly Phenotypic Correction of Diabetic Mice by Adenovirus-Mediated Glucokinase Expression Diabetes, October 1, 2001; 50(10): 2287 - 2295. [Abstract] [Full Text]

				E. D. Slosberg, U. J. Desai, B. Fanelli, I. St. Denny, S. Connelly, M. Kaleko, B. R. Boettcher, and S. L. Caplan Treatment of Type 2 Diabetes by Adenoviral-Mediated Overexpression of the Glucokinase Regulatory Protein Diabetes, August 1, 2001; 50(8): 1813 - 1820. [Abstract] [Full Text] [PDF]

				M. Shiota, C. Postic, Y. Fujimoto, T. L. Jetton, K. Dixon, D. Pan, J. Grimsby, J. F. Grippo, M. A. Magnuson, and A. D. Cherrington Glucokinase Gene Locus Transgenic Mice Are Resistant to the Development of Obesity-Induced Type 2 Diabetes Diabetes, March 1, 2001; 50(3): 622 - 629. [Abstract] [Full Text]

				J. Seoane, A. Barbera, S. Telemaque-Potts, C. B. Newgard, and J. J. Guinovart Glucokinase Overexpression Restores Glucose Utilization and Storage in Cultured Hepatocytes from Male Zucker Diabetic Fatty Rats J. Biol. Chem., November 5, 1999; 274(45): 31833 - 31838. [Abstract] [Full Text] [PDF]

				R. Gasa, P. B. Jensen, H. K. Berman, M. J. Brady, A. A. DePaoli-Roach, and C. B. Newgard Distinctive Regulatory and Metabolic Properties of Glycogen-targeting Subunits of Protein Phosphatase-1 (PTG, GL, GM/RGl) Expressed in Hepatocytes J. Biol. Chem., August 18, 2000; 275(34): 26396 - 26403. [Abstract] [Full Text] [PDF]

				T. H. van Dijk, F. H. van der Sluijs, C. H. Wiegman, J. F. W. Baller, L. A. Gustafson, H.-J. Burger, A. W. Herling, F. Kuipers, A. J. Meijer, and D.-J. Reijngoud Acute Inhibition of Hepatic Glucose-6-phosphatase Does Not Affect Gluconeogenesis but Directs Gluconeogenic Flux toward Glycogen in Fasted Rats. A PHARMACOLOGICAL STUDY WITH THE CHLOROGENIC ACID DERIVATIVE S4048 J. Biol. Chem., July 6, 2001; 276(28): 25727 - 25735. [Abstract] [Full Text] [PDF]

				R. Yang, L. Cao, R. Gasa, M. J. Brady, A. D. Sherry, and C. B. Newgard Glycogen-targeting Subunits and Glucokinase Differentially Affect Pathways of Glycogen Metabolism and Their Regulation in Hepatocytes J. Biol. Chem., January 4, 2002; 277(2): 1514 - 1523. [Abstract] [Full Text] [PDF]

				R. Gasa, C. Clark, R. Yang, A. A. DePaoli-Roach, and C. B. Newgard Reversal of Diet-induced Glucose Intolerance by Hepatic Expression of a Variant Glycogen-targeting Subunit of Protein Phosphatase-1 J. Biol. Chem., January 4, 2002; 277(2): 1524 - 1530. [Abstract] [Full Text] [PDF]